We are live on
!
Find out more
TCM
Tufton Capital Management Portfolio holdings
AUM
$596M
1-Year Est. Return
37.37%
This Fund
S&P 500
This Quarter
Est. Return
+1.72%
1 Year Est. Return
+37.37%
3 Year Est. Return
+86.54%
5 Year Est. Return
+98.63%
10 Year Est. Return
+299.31%
AUM
$493M
AUM Growth
-$14.7M
(-2.9%)
Cap. Flow
-$21.8M
Cap. Flow
% of AUM
-4.42%
Top 10 Holdings %
Top 10 Hldgs %
30.85%
Holding
131
New
6
Increased
29
Reduced
61
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.76M |
| 2 |
Helmerich & Payne
HP
|
+$1.29M |
| 3 |
Verizon
VZ
|
+$648K |
| 4 |
DXC Technology
DXC
|
+$592K |
| 5 |
Chesapeake Utilities
CPK
|
+$504K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McCormick & Company Voting
MKC.V
|
+$20.2M |
| 2 |
JPMorgan Chase
JPM
|
+$1.58M |
| 3 |
Norfolk Southern
NSC
|
+$1.37M |
| 4 |
Oracle
ORCL
|
+$1.27M |
| 5 |
Microsoft
MSFT
|
+$880K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 23.46% |
| 2 | Industrials | 15.44% |
| 3 | Technology | 13.96% |
| 4 | Healthcare | 11.57% |
| 5 | Financials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Altria Group
MO
$114B
| $3.84M | 0.78% |
51,591
-290
| -0.6% | -$21.2K |
|
52
Coca-Cola
KO
$377B
| $3.79M | 0.77% |
84,434
+2,790
| +3% | +$123K |
|
53
Boeing
BA
$171B
| $3.72M | 0.75% |
18,795
-634
| -3% | -$118K |
|
54
Bank of America
BAC
$435B
| $3.44M | 0.7% |
141,905
+12,326
| +10% | +$287K |
|
55
Zoetis
ZTS
$32.4B
| $3.39M | 0.69% |
54,387
-255
| -0.5% | -$15.1K |
|
56
Olin
OLN
$2.11B
| $3.2M | 0.65% |
105,550
-740
| -0.7% | -$22.6K |
|
57
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $2.72M | 0.55% |
11,251
+162
| +1% | +$38.8K |
|
58
Leggett & Platt
LEG
$1.34B
| $2.69M | 0.54% |
51,108
-395
| -0.8% | -$20.6K |
|
59
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
| $2.56M | 0.52% |
11,995
-22
| -0.2% | -$4.62K |
|
|
CELG
60
DELISTED
Celgene Corp
CELG
| $2.26M | 0.46% |
17,422
+2,247
| +15% | +$275K |
|
61
Sysco
SYY
$40.8B
| $2.16M | 0.44% |
42,950
-405
| -0.9% | -$21.6K |
|
62
Alphabet (Google) Class A
GOOGL
$4.36T
| $2.08M | 0.42% |
44,720
-320
| -0.7% | -$15K |
|
63
Capital One
COF
$128B
| $2M | 0.4% |
24,151
-6,770
| -22% | -$550K |
|
|
TIF
64
DELISTED
Tiffany & Co.
TIF
| $1.78M | 0.36% |
18,938
-20
| -0.1% | -$1.84K |
|
65
TSMC
TSM
$2.1T
| $1.65M | 0.34% |
47,233
-755
| -2% | -$26.1K |
|
|
VAR
66
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.53M | 0.31% |
14,845
| – | – |
|
67
Hewlett Packard
HPE
$63.4B
| $1.42M | 0.29% |
110,519
-39,324
| -26% | -$548K |
|
68
Teva Pharmaceuticals
TEVA
$40.8B
| $1.34M | 0.27% |
40,328
+2,295
| +6% | +$71K |
|
69
PNC Financial Services
PNC
$99.7B
| $1.32M | 0.27% |
10,611
-75
| -0.7% | -$9.05K |
|
70
Berkshire Hathaway Class B
BRK.B
$1.1T
| $1.11M | 0.23% |
6,559
+785
| +14% | +$131K |
|
71
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $1.06M | 0.22% |
25,975
+2,425
| +10% | +$98.3K |
|
72
Elevance Health
ELV
$81.5B
| $995K | 0.2% |
5,290
-125
| -2% | -$22.5K |
|
73
Apple
AAPL
$4.54T
| $966K | 0.2% |
26,824
+808
| +3% | +$29.9K |
|
74
State Street SPDR S&P Dividend ETF
SDY
$21.7B
| $875K | 0.18% |
9,844
+1,060
| +12% | +$93.9K |
|
75
Hercules Capital
HTGC
$3.07B
| $753K | 0.15% |
56,906
-13,596
| -19% | -$189K |
|
Similar funds
BWP
TAIM
BCM
ECM
FSG
ESL
SCM
GP
Tufton Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Tufton Capital Management held 131 positions worth $493M, down 2.9% from $507M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Tufton Capital Management withdrew a net $21.8M in Q2 2017, closing 4 positions and reducing 61 holdings. Its most notable exit was Vanguard FTSE Developed Markets ETF, an estimated $609K position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, down from 26% a quarter earlier, followed by Industrials and Technology.
Against the trend, Tufton Capital Management opened a new position in DXC Technology worth $592K.
- Tufton Capital Management's largest Q2 2017 buy was DXC Technology: 8,920 shares worth $592K.
- Tufton Capital Management added most to Bristol-Myers Squibb in Q2 2017, an estimated $1.76M increase.
- Tufton Capital Management's biggest Q2 2017 reduction was McCormick & Company Voting, cutting an estimated $20.2M.
- Tufton Capital Management fully exited Vanguard FTSE Developed Markets ETF in Q2 2017, selling an estimated $609K.
- Tufton Capital Management's ten largest holdings make up 31% of its $493M portfolio in Q2 2017.
- Tufton Capital Management opened 6 new positions and closed 4 in Q2 2017.
- Tufton Capital Management's portfolio value fell 2.9% quarter-over-quarter to $493M.
Based on Tufton Capital Management's 13F filing for Q2 2017, filed 28 Jul 2017.